BioBusiness

BioBusiness

Home
Chat
Archive
About

August 2023

The Race to Commercialization: Examining the Current NASH Pipeline
Nonalcoholic steatohepatitis (NASH) it’s the more severe form of Nonalcoholic fatty liver disease (NAFLD) which is characterized by the accumulation of…
 • 
Adrian Rubstein
The Race to Commercialization: Examining the Current NASH Pipeline
Nonalcoholic steatohepatitis (NASH) it’s the more severe form of Nonalcoholic fatty liver disease (NAFLD) which is characterized by the accumulation of…
 • 
Adrian Rubstein
Harnessing the Immune System to Target Solid Tumors - CAR-M Technology
Solid tumors are a major challenge in cancer therapy, as they often resist conventional treatments and metastasize to other organs.
 • 
Adrian Rubstein
Unlocking the Undruggable Proteome with Targeted Protein Degradation
The cell is a complex system with over 20,000 individual proteins carrying out coordinated biological processes.
 • 
Adrian Rubstein
Harnessing the Immune System to Target Solid Tumors - CAR-M Technology
Solid tumors are a major challenge in cancer therapy, as they often resist conventional treatments and metastasize to other organs.
 • 
Adrian Rubstein
Join my chat
A private space for us to converse and connect
 • 
Adrian Rubstein
When CRISPR meets Dark Genome: Epigenetic Editing
Innovation happens fast in the Biotech industry and the technologies are being superseded a new technology even faster than before.
 • 
Adrian Rubstein

March 2023

Using Digital Twins To Improve Drug Development and Delivery
Drug delivery is a complex process involving numerous factors such as drug properties, patient physiology, and delivery mechanisms.
 • 
Adrian Rubstein
Closing the Gender Gap: An Overview of FemTech and Its Potential
Over the last few decades, there has been a significant shift in the development of technology focusing on women's health.
 • 
Adrian Rubstein
Big Money in Biotech: Private Equity Firms Betting Big
Private equity firms have been increasingly investing in biotechnology companies and funds in recent years, as they see the potential for high returns…
 • 
Adrian Rubstein
Harnessing the Power of the Brain in Investing
Investing can be a complex and challenging task that requires a great deal of knowledge, expertise, and intuition.
 • 
Adrian Rubstein
© 2025 Adrian Rubstein
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture